This article is a correction to:
Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot
Jiezhi Dai
Yu Zhou
Shasha Mei3*
Hua Chen- 1Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
- 2Department of Orthopedic Surgery, Civil Aviation Hospital of Shanghai, Shanghai, China
- 3Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
A Corrigendum on
Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot.
by Dai J, Zhou Y, Mei S and Chen H (2022) 13:1009714. doi: 10.3389/fendo.2022.1009714
In the published article, there was an error in Figure 1 as published. As the authors were careless in picture editing, they have amended the figure to provide improved clarity. The corrected Figure 1 and its caption "Case 1: Te distally based sural neurocutaneous flaps for reconstruction of the heel soft tissue defect. (A) Diabetic wound at the heel. (B) Harvest of the distally based sural neurocutaneous flap. (C) The defect was reconstructed with a flap, and the donor site was covered with skin graft. (D) The flap and the donor site were completely healed at follow-up" appear below.
FIGURE 1
Figure 1 Case 1: Te distally based sural neurocutaneous flaps for reconstruction of the heel soft tissue defect. (A) Diabetic wound at the heel. (B) Harvest of the distally based sural neurocutaneous flap. (C) The defect was reconstructed with a flap, and the donor site was covered with skin graft. (D) The flap and the donor site were completely healed at follow-up.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: diabetic foot, diabetic wound defect, distally based sural flap, wound healing, foot and ankle reconstruction
Citation: Dai J, Zhou Y, Mei S and Chen H (2022) Corrigendum: Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot. Front. Endocrinol. 13:1054322. doi: 10.3389/fendo.2022.1054322
Received: 26 September 2022; Accepted: 08 November 2022;
Published: 23 November 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Dai, Zhou, Mei and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hua Chen, Y2h1YWRyQGFsaXl1bi5jb20=; Shasha Mei, MTU1MDIxMjQ5MTJAMTYzLmNvbQ==
†These authors have contributed equally to this work and share first authorship